Laura Hunter
Family Medicine · Richmond, VANPI 1578520540
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 212 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,138 and has fallen 98.4% since, to $18 in 2025.
Across 212 payments — averaging $14.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$482
- Novo Nordisk$385
- AbbVie$328
- Amgen$307
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$235
- GSK$158
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,10199%
- Education$381%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 30 | $482 |
| Novo Nordisk | 32 | $385 |
| AbbVie(2 entities) | 22 | $328 |
| Amgen | 22 | $307 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $235 |
| GSK | 6 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $124 |
| Irhythm Technologies, Inc. | 2 | $111 |
| Teva Pharmaceuticals USA, Inc. | 8 | $109 |
| AstraZeneca | 6 | $77 |
| Pfizer | 6 | $73 |
| Sanofi-aventis U.S. LLC | 5 | $70 |
| Boehringer Ingelheim | 4 | $65 |
| Biohaven Pharmaceuticals, Inc. | 4 | $63 |
| Novartis | 4 | $56 |
| Lilly USA, LLC | 4 | $49 |
| Johnson & Johnson | 4 | $45 |
| Shire North American Group Inc | 3 | $43 |
| Merck | 3 | $41 |
| Kowa Pharmaceuticals America, Inc. | 3 | $39 |
| AMAG Pharmaceuticals, Inc. | 2 | $38 |
| Upsher-smith Laboratories LLC | 2 | $36 |
| Genentech USA, Inc. | 2 | $35 |
| Abbott | 2 | $30 |
| Astellas Pharma US Inc | 2 | $29 |
| Mannkind Corporation | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Bayer | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Amneal Pharmaceuticals LLC | 1 | $12 |
How this compares
$3,138 in reported general payments places this provider in the 85th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Richmond
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- James FosterRichmond$27K
- Daniel DavidRichmond$16K
- Douglas KlassettRichmond$16K
- James ZelenakRichmond$15K
- David SteinRichmond$15K
- Richard TateRichmond$14K
- Oluwaronke AwosikaFort Gregg Adams$397K
- Monique MatuskowitzNorfolk$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.